MedTrace Logo

Validity and Reliability of the PRAFAB

NCT07339657 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 63

Last updated 2026-01-14

No results posted yet for this study

Summary

PRAFAB assesses both the objective and subjective aspects of urinary incontinence. While differing from other questionnaires in this respect, it consists of only five questions. Today, there is a need for multidimensional and easy-to-use scales that can assess the effects of incontinence on quality of life. Therefore, the aim of this study is to conduct a Turkish validity and reliability study of the PRAFAB questionnaire in women with urinary incontinence.

Conditions

Interventions

OTHER

Construct validity

This is not an intervention. This is an analysis conducted to examine the factor structure of this questionnaire. The analysis will be performed using the SPSS 26.0 software package program.

OTHER

Test-retest reliability

This is not an intervention. This is an analysis conducted to examine the repeatability of this questionnaire. The analysis will be performed using the SPSS 26.0 software package program.

Sponsors & Collaborators

  • Afyonkarahisar Health Sciences University

    lead OTHER

Principal Investigators

  • EMEL TAŞVURAN HORATA · Afyonkarahisar Sağlık Bİlimleri Üniversitesi

  • Şeyma Betül İNCE · No Affiliation

  • Harun TAŞKIN, PhD · Afyonkarahisar Health Sciences University

  • Osman GERÇEK, MD · Afyonkarahisar Health Sciences University

  • Mustafa Esat İNCE, MD · Afyonkarahisar Health Sciences University

  • Bary Berghmans, Assoc. Prof. · Maastricht University

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-15
Primary Completion
2026-08-15
Completion
2026-08-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07339657 on ClinicalTrials.gov